Myriad Genetics, Inc. · NASDAQ:MYGN
Skovronsky Daniel received 59,701 Myriad Genetics, Inc. shares as an award (Form 4)
Traded Jun 4, 2026 · Filed Jun 5, 2026
On Jun 4, 2026, Skovronsky Daniel (Director) received 59,701 Myriad Genetics, Inc. shares as an award, leaving 195,507 shares. Filed Jun 5, 2026 (Form 4).
- Awarded
- 59,701 shares
- Holding after
- 195,507 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Common Stock | Award | 59,701 | 195,507 | Direct |
Source
Related
- Myriad Genetics, Inc.
- Skovronsky Daniel
- Myriad Genetics, Inc. shareholders
- Form 4 · Wheeler Benjamin Richard · Sep 22, 2026
- Form 4 · Sikri Vishal · Sep 17, 2026
- Form 4 · Fox Jennifer Lynne · Sep 8, 2026
- Schedule 13G · BlackRock Portfolio Management LLC · Sep 4, 2026
- Form 4 · Wheeler Benjamin Richard · Aug 17, 2026